title: Effect of suleparoide on fibrinolysis in the anterior chamber of rabbits.
abstract: Intra-ocular fibrin deposition following ocular surgery is a serious postoperative complication. The current management of severe postoperative fibrin response is usually ineffective. A quantitative model of fibrin deposition in the rabbit anterior chamber was used to assess the efficacy of Suleparoide I.N.N. (HHS-5) in preventing fibrin formation and in promoting the clearance of fibrinous membranes. Citrated human plasma was injected intracamerally after paracentesis to induce the formation of fibrin clots: 10 min or 24 h after plasma injection, solutions of HHS-5 at different concentrations were injected into the anterior chamber of rabbits. Intra-ocular HHS-5 injection 10 min after plasma injection prevented the formation of fibrinous membranes in a dose-dependent fashion in almost all treated animals. When HHS-5 was injected at 24 h after fibrin clot formation, a reduction of clot areas was observed but the membranes did not completely disappear. No evidence of ocular toxicity was detected by slit-lamp biomicroscopy, intra-ocular pressure and corneal thickness measurements. On the basis of the results obtained with the present animal model, HHS-5 appears as an effective and safe agent for the prevention of fibrinous membrane formation. The data suggest a potential use of HHS-5 for the prophylaxis of fibrin formation in human eyes undergoing extensive intraocular surgery, or in diabetic patients where a hypercoagulable state may be present.
authors.affiliation: Institute of Ophthalmology, University of Pisa, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Lepri
authors.forename: U
authors.initials: U
authors.lastname: Benelli
authors.forename: P
authors.initials: P
authors.lastname: Chetoni
authors.forename: G
authors.initials: G
authors.lastname: Perini
authors.forename: M F
authors.initials: MF
authors.lastname: Saettone
authors.forename: M
authors.initials: M
authors.lastname: Nardi
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000867:Anterior Chamber / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005500:Follow-Up Studies; D006497:Heparan Sulfate / Q000494:pharmacology*; D007429:Intraocular Pressure; D008297:Male; D011817:Rabbits
chemical_list: D005343:Fibrinolytic Agents; D006497:Heparan Sulfate; C082900:suleparoid